PB Ratio: 5.60

Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 5.60 is 26% above its estimated 2-year average of 4.44, around the middle of its estimated 2-year range (1.38–7.54).

As of 2026-10-06T14:56:18.745Z. 1.26% below its estimated 12-month average of 5.67.

CGON PB Ratio Metrics

P/B vs. estimated history

At 5.60, P/B is above its estimated 2-year median — higher than 78% of readings in its estimated 2-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)

The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for CG Oncology Inc. (CGON)?

The P/B ratio for CGON stock is 5.60.

Is CG Oncology Inc.'s P/B ratio high or low?

The P/B ratio of 5.60 is 26% above its estimated 2-year average of 4.44, around the middle of its estimated 2-year range (1.38–7.54).

What is the estimated TTM average P/B ratio for CG Oncology Inc. (CGON)?

The estimated TTM average P/B ratio for CGON stock is 5.67.

Showing the most recent 260 of 602 data points. The chart above shows the full history.

Related Metrics